BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38673700)

  • 1. Usefulness of Combined Measurement of Surfactant Protein D, Thrombin-Antithrombin III Complex, D-Dimer, and Plasmin-α2 Plasmin Inhibitor Complex in Acute Exacerbation of Interstitial Lung Disease: A Retrospective Cohort Study.
    Takeshita Y; To M; Kurosawa Y; Furusho N; Kinouchi T; Tsushima K; Tada Y; To Y; Sakao S
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673700
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
    Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors.
    Asanuma K; Nakamura T; Hagi T; Okamoto T; Kita K; Nakamura K; Matsuyama Y; Yoshida K; Asanuma Y; Sudo A
    BMC Cancer; 2021 Apr; 21(1):364. PubMed ID: 33827473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?
    Asanuma K; Nakamura T; Okamoto T; Hagi T; Kita K; Nakamura K; Matsuyama Y; Yoshida K; Asanuma Y; Sudo A
    BMC Cancer; 2022 Oct; 22(1):1075. PubMed ID: 36258189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.
    Cheng Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Zhang W; Wu J
    Clin Appl Thromb Hemost; 2019; 25():1076029619877458. PubMed ID: 31608652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
    Wang L; Zhong J; Xiao D; Huang W; Zheng Z; Jiang Y
    Ann Transl Med; 2022 Dec; 10(23):1273. PubMed ID: 36618792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease.
    Saigusa R; Asano Y; Nakamura K; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Yoshizaki A; Miyazaki M; Tamaki Z; Sato S
    Mod Rheumatol; 2017 Jul; 27(4):618-622. PubMed ID: 27538472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
    Rai M; Parthasarathi A; Beeraka NM; Kaleem Ullah M; Malamardi S; Padukudru S; Siddaiah JB; Uthaiah CA; Vishwanath P; Chaya SK; Ramaswamy S; Upadhyay S; Ganguly K; Mahesh PA
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
    Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
    Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients.
    Takeshita Y; Terada J; Hirasawa Y; Kinoshita T; Tajima H; Koshikawa K; Kinouchi T; Isaka Y; Shionoya Y; Fujikawa A; Tada Y; Nakaseko C; Tsushima K
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of prothrombotic state in ischemic stroke by monitoring plasma molecular markers.
    Nagayama M; Shinohara Y; Nagayama T
    J Stroke Cerebrovasc Dis; 1994; 4(4):250-4. PubMed ID: 26486246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of Coagulation and Fibrinolysis Biomarker in Lung Cancer Patients with Thromboembolism].
    Fu Y; Liu Y; Jin Y; Jiang H
    Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):583-587. PubMed ID: 30172264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
    Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome.
    Li S; Qian Y; Pei Y; Wu K; Lu S
    Front Med (Lausanne); 2021; 8():720342. PubMed ID: 34513881
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer.
    Fidan E; Kavgaci H; Orem A; Yilmaz M; Yildiz B; Fidan S; Akcan B; Ozdemir F; Aydin F
    Tumour Biol; 2012 Oct; 33(5):1519-25. PubMed ID: 22535370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.